Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

tippy_09137 1 post  |  Last Activity: Mar 8, 2015 8:24 AM Member since: Dec 9, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • tippy_09137 by tippy_09137 Mar 8, 2015 8:24 AM Flag

    Anyone following this stock? Looks like has great growth potential.

    "We are extremely pleased with the growth of Forfivo XL(R) throughout 2014 and we believe that this growth will continue, especially as Edgemont increased its salesforce threefold in mid-December, 2014" stated Dr. Horst G. Zerbe, President and CEO of IntelGenx. "The marketing and sales efforts that our partner, Edgemont Pharmaceuticals, has invested in the commercialization of Forfivo XL(R) have ensured that a more convenient and safe alternative for patients requiring high-dose anti-depressant therapy is widely available in the US. Forfivo XL(R) generated in excess of $1.1 million (unaudited) of revenue for IntelGenx in 2014 and we anticipate significantly higher revenue from the product in 2015."

INSM
21.09+0.59(+2.88%)Mar 30 4:00 PMEDT